FDA NDC Directory · JSON-LD · Markdown

Sitagliptin

NDC 0480-2608 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA202327
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsSITAGLIPTIN PHOSPHATE (50 mg/1)
Marketing started20260528
Package count2

External sources

Source: openFDA. Public-domain (CC0).